Cited by 1,283Opioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesPoisoning and overdose treatments

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Drug Overdose Deaths in the United States, 1999–2020

Open access

Hedegaard, Holly, Miniño, Arialdi, Spencer, Merianne Rose, Warner, Margaret·2021

Open this paper in CoChat — free account Open PDF

Abstract

This report uses the most recent data from the National Vital Statistics System (NVSS) to update statistics on deaths from drug overdose in the United States, showing rates by demographic group and by specific types of drugs involved (such as opioids or stimulants), with a focus on changes from 2019 to 2020.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.15620/cdc:112340

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

National Center for Health Statistics Guidelines for Analysis of Trends.
Ingram, D. D., Malec, D. J., Makuc, D. M., Kruszon‐Moran, D., Gindi, R. M., Albert, M., Beresovsky, V., Hamilton, B. E., Holmes, J. S., Schiller, J. S., et al. (2018) · PubMed · Cited by 783
Drug Overdose Deaths in the United States, 2003–2023
Garnett, M. F., Miniño, A., Joyce, M. A., Driscoll, A., & Valenzuela, C. (2024) · doi:10.15620/cdc/170565 · Cited by 390
Self-citation
Deaths: Final Data for 2019
Xu, J., Murphy, S., Arias, E., & Kochanek, K. D. (2021) · doi:10.15620/cdc:106058 · Cited by 107
The contribution of drug-related deaths to the US disadvantage in mortality
Barbiéri, M. (2018) · International Journal of Epidemiology · doi:10.1093/ije/dyy288 · Cited by 30

Show all 4 references

Research works printed but not linked: 1

Office of Management and Budget. Revisions to the standards for the classification of federal data on race and ethnicity. Fed Regist 62(210):58782-90. 1997. Available from: https://www.govinfo.gov/content/ pkg/FR-1997-10-30/pdf/97-28653.pdf.

Sorted by citations

Items 801–900 of 1,002

Enhancing research data infrastructure to address the opioid epidemic: the Opioid Overdose Network (O2-Net)
Lenert, L. A., Zhu, V. J., Jennings, L. K., McCauley, J. L., Obeid, J. S., Ward, R. C., Hassanpour, S., Marsch, L. A., Hogarth, M. A., Shipman, P., et al. (2022) · JAMIA Open · doi:10.1093/jamiaopen/ooac055 · Cited by 7
Psychological distress and the risk of drug overdose death
Aram, J., Spencer, M. R. T., Garnett, M. F., & Hedegaard, H. B. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.115 · Cited by 7
Self-citation
Overdose Experiences among People Who Inject Drugs in West Virginia: Personal Loss, Psychological Distress, Naloxone, and Fentanyl
Schneider, K. E., Allen, S. T., Winiker, A. K., White, R. H., O’Rourke, A., Sherman, S. G., & Grieb, S. M. D. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2136489 · Cited by 7
Sex differences in the prevalence and correlates of emergency department utilization among adults with prescription opioid use disorder
John, W. S., & Wu, L.-T. T. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2019.1568495 · Cited by 7
Hospitals and substance use disorder services in the time of the opioid epidemic
Cronin, C. E., Franz, B. A., Skinner, D., & Haile, Z. T. (2019) · Health Services Research · doi:10.1111/1475-6773.13116 · Cited by 7
Prescription Drug Abuse Among Patients in Rural Dental Practices Reported by Members of the National Dental PBRN
McCauley, J. L., Nelson, J., Gilbert, G. H., Gordan, V. V., Durand, S. H., Mungia, R., Meyerowitz, C., Leite, R. S., Fillingim, R. B., Brady, K. T., et al. (2019) · The Journal of Rural Health · doi:10.1111/jrh.12386 · Cited by 7
Mental health conditions and the risk of chronic opioid therapy among patients with rheumatoid arthritis: a retrospective veterans affairs cohort study
Liberman, J. S., McGowan, L. D., Greevy, R. A., Morrow, J. A., Griffin, M. R., Roumie, C. L., & Grijalva, C. G. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-04955-2 · Cited by 7
Estimating the burden of the opioid epidemic for adults and adolescents in Ohio counties
Kline, D., & Hepler, S. A. (2020) · Biometrics · doi:10.1111/biom.13295 · Cited by 7
Implementation of strength-based case management for opioid-dependent patients presenting in medical emergency departments: rationale and study design of a randomized trial
Regis, A., Meyers-Ohki, S. E., Mennenga, S. E., Greco, P. P., Glisker, R., Kolaric, R., McCormack, R. P., Rapp, R. C., & Bogenschutz, M. P. (2020) · Trials · doi:10.1186/s13063-020-04684-6 · Cited by 7
Gender differences in the relationship between prescription opioid misuse and depressive symptoms and suicidality among US High School Students
Pontes, N. M. H., Ayres, C., Wunnenberg, M., & Pontes, M. (2021) · Nursing Outlook · doi:10.1016/j.outlook.2021.01.006 · Cited by 7
Effectiveness of eHealth Technology–Based Interventions in Reducing Substance Misuse Among Older Adults: A Systematic Review
Kazemi, D. M., Troutman‐Jordan, M., Whitfield, J. E., & Pappa, E. V. (2021) · Journal of Gerontological Nursing · doi:10.3928/00989134-20210908-04 · Cited by 7
Characterizing Pharmacist Perspectives on Utilizing a Personalized Family Medication Safety Plan for Opioid Education with Adolescents and Parents
Abraham, O., Peters, J., & Peterson, K. A. (2023) · Pharmacy · doi:10.3390/pharmacy11010022 · Cited by 7
Closing the gaps in opioid use disorder research, policy and practice: conference proceedings
Miclette, M., Leff, J. A., Cuan, I., Samet, J. H., Saloner, B. K., Mendell, G., Bao, Y., Ashburn, M. A., Bachhuber, M. A., Schackman, B. R., et al. (2018) · Addiction Science & Clinical Practice · doi:10.1186/s13722-018-0123-3 · Cited by 7
Outcomes after opioid dose reductions and stoppage: It's time to start counting
Kertesz, S. G. (2019) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2019.05.010 · Cited by 7
The Role of Family in Youth Opioid Misuse: A Literature Review
Kaur, L., Tadros, E., & Patton, R. (2019) · The Family Journal · doi:10.1177/1066480719868705 · Cited by 7
Cerebrospinal fluid neurotransmitter levels and central nervous system depression in a rat drug overdose model
Tsutsumi, H., Yonemitsu, K., Sasao, A., Ohtsu, Y., Furukawa, S., & Nishitani, Y. (2019) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2019.1672122 · Cited by 7
Youth Perspectives of Prescription Pain Medication in the Opioid Crisis
Harbaugh, C. M., Vu, J. V.-T., DeJonckheere, M. J., Kim, N., Nichols, L. P., & Chang, T. (2020) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2020.02.003 · Cited by 7
Clinician Perceptions About a Decision Support System to Identify and Manage Opioid Use Disorder
Solberg, L. I., Hooker, S. A., Rossom, R. C., Bergdall, A. R., & Crabtree, B. F. (2021) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2021.06.210126 · Cited by 7
Unhappiness and age
Blanchflower, D. G. (2020) · National Bureau of Economic Research · doi:10.3386/w26642 · Cited by 7
Excess Mortality in the United States, 2020-21: County-level Estimates for Population Groups and Associations with Social VulnerabilityPreprint
Kandula, S., Keyes, K. M., Yaari, R., & Shaman, J. L. (2024) · medRxiv · doi:10.1101/2024.01.14.24301290 · Cited by 7
Risk Factors for Self-Harm Ideation among Persons Treated with Opioids for Chronic Low Back Pain
Jamison, R. N., Edwards, R. R., Brown, R., Barrett, B. P., Burzinski, C. A., Lennon, R. P., Nakamura, Y., Schiefelbein, T., Garland, E. L., & Zgierska, A. E. (2023) · The Clinical Journal of Pain · doi:10.1097/ajp.0000000000001161 · Cited by 6
Development and validation of a combined selected ion monitoring‐scan GC ‐ EI ‐ MS method for nitazene analogs
Phelps, C., Hardwick, E. K., Couch, A. N., & Davidson, J. T. (2025) · Journal of Forensic Sciences · doi:10.1111/1556-4029.70084 · Cited by 6
Stimulant-involved overdose deaths: Constructing dynamic hypotheses
Hasgül, Z., Deutsch, A. R., Jalali, M. S., & Stringfellow, E. J. (2025) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2025.104702 · Cited by 6
The evaluation of mandatory alerts on long-acting opioid prescriptions and the use of a community pharmacy naloxone protocol
Coffman, R., Johnson, A., Frede, S. M., Pleiman, M., & Johnson, K. (2021) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2021.11.032 · Cited by 6
Methamphetamine use and illicit opioid use during buprenorphine treatment
Kratina-Hathaway, Z., Radick, A. C., Leroux, B. G., Blalock, K. L., Kim, T. W., Darnton, J. B., Saxon, A. J., Samet, J. H., & Tsui, J. I. (2023) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2022.208934 · Cited by 6
A detailed study of a prominent dark web fentanyl trafficking organization
Caulkins, J. P., Schicker, P. C., Milward, H. B., & Reuter, P. (2023) · Global Crime · doi:10.1080/17440572.2023.2291352 · Cited by 6
Impact of the Narcotics Information Management System on Opioid Use Among Outpatients With Musculoskeletal and Connective Tissue Disorders: Quasi-Experimental Study Using Interrupted Time Series
Lee, I., Kim, S. Y., Park, S., Ryu, J. G., & Je, N. K. (2024) · JMIR Public Health and Surveillance · doi:10.2196/47130 · Cited by 6
Shifting Cohort Patterns in the Use of Drugs with Elevated Overdose Risk in the United States
England, K., Luo, L., Verdery, A. M., & Monnat, S. M. (2024) · Social Problems · doi:10.1093/socpro/spae013 · Cited by 6
Characterization of peer support services for substance use disorders in 11 US emergency departments in 2020: findings from a NIDA clinical trials network site selection process
Jennings, L. K., Lander, L. R., Lawdahl, T., McClure, E. A., Moreland, A. D., McCauley, J. L., Haynes, L. F., Matheson, T., Jones, R. N., Robey, T. E., et al. (2024) · Addiction Science & Clinical Practice · doi:10.1186/s13722-024-00453-x · Cited by 6
Community-led approaches to making naloxone available in public settings: Implementation experiences in the HEALing communities study
Starbird, L. E., Onuoha, E. N., Corry, G. J., Hotchkiss, J., Benjamin, S. N., Hunt, T., Schackman, B. R., & El‐Bassel, N. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104462 · Cited by 6
The microbiome’s influence on the neurobiology of opioid addiction and brain connectivity
Iriah, S. C., Rodriguez, N., Febo, M., Morrissette, M., Strandwitz, P., Kulkarni, P., & Ferris, C. F. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.111159 · Cited by 6
Impact of Intracellular Proteins on μ-Opioid Receptor Structure and Ligand Binding
Scott, C. E., Juechter, L. A., Rocha, J., Jones, L. D., Outten, B., Aishman, T. D., Ivers, A. R., & Shields, G. C. (2024) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c05214 · Cited by 7
Time-to-scene for opioid overdoses: are unmanned aerial drones faster than traditional first responders in an urban environment?
Tukel, C., Tukel, M. R., Weinbaum, R. J., Mika, V. H., & Levy, P. D. (2020) · BMJ Innovations · doi:10.1136/bmjinnov-2019-000357 · Cited by 6
Substance Use Treatment Engagement among Men Who Have Sex with Men Who Use Stimulants in the Northeastern United States
Viera, A., Sosnowy, C. D., van den Berg, J. J., Mehta, N. A., Edelman, E. J., Kershaw, T., & Chan, P. A. (2022) · Substance Use & Misuse · doi:10.1080/10826084.2022.2026965 · Cited by 6
Adverse childhood experiences are associated with increased overdose risk in predominately Latinx adults seeking treatment for substance use disorders
Tschampl, C. A., Canuto, M., Jesús, D. D., D'Ippolito, M., Guzman, M., Larson, M. J., Stewart, E. A., & Lundgren, L. M. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.987085 · Cited by 6
MicroRNA-mediated translational pathways are regulated in the orbitofrontal cortex and peripheral blood samples during acute abstinence from heroin self-administration
Zanda, M. T., Saikali, L., Morris, P., & Daws, S. E. (2023) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2023.11668 · Cited by 6
Software‐assisted automated detection and identification of “unknown” fentanyl analogues
Drug, E., Marder, D., Binyamin, I., Yeffet, D., Gershonov, E., & Dagan, S. (2023) · Journal of Mass Spectrometry · doi:10.1002/jms.4994 · Cited by 6
Evidence that intergenerational income mobility is the strongest predictor of drug overdose deaths in U. S. Midwest counties
Heyman, G. M., Ryu, E., & Brownell, H. (2024) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2024.104558 · Cited by 6
Change and variability in drug treatment coverage among people who inject drugs in 90 large metropolitan areas in the USA, 1993–2007
Tempalski, B., Cleland, C. M., Williams, L. D., Cooper, H. L. F., & Friedman, S. R. (2018) · Substance Abuse Treatment Prevention and Policy · doi:10.1186/s13011-018-0165-2 · Cited by 6
Impact of Targeted Temperature Management on ED Patients with Drug Overdose–Related Cardiac Arrest
Khan, S. S., Meyers, C. M., Bentley, S., & Manini, A. F. (2018) · Journal of Medical Toxicology · doi:10.1007/s13181-018-0686-0 · Cited by 6
A Comparison of Efficacy of Treatment and Time to Administration of Naloxone by BLS and ALS Providers
NUGENT, K. M., Matthews, P., Gissendaner, J., Papas, M. A., Occident, D., Patel, A., Johnson, M. L., Megargel, R. E., & Nomura, J. T. (2019) · Prehospital and Disaster Medicine · doi:10.1017/s1049023x19004527 · Cited by 6
A Prospective Study of Service Use in the Year After Birth by Women at High Risk for Antenatal Substance Use and Mental Health Disorders
Stevens, S., Rogers, J., Dansereau, L. M., DellaGrotta, S. A., Lester, B. M., & Wouldes, T. A. (2019) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-019-00207-w · Cited by 7
Confronting the opioid crisis with consumer health information: a look at East Tennessee
Grabeel, K. L., & Moore, J. C. (2021) · Journal of the Medical Library Association JMLA · doi:10.5195/jmla.2021.1015 · Cited by 6
Community Legal Systems: Targeting PrEP and HIV Education to Decrease Risk of HIV Transmission
Whiteside-Mansell, L., Sockwell, L., Knight, D. A., & Crone, C. C. (2021) · AIDS and Behavior · doi:10.1007/s10461-021-03219-7 · Cited by 6
If you cannot measure it, you cannot improve it
Albrecht, É., & Brummett, C. M. (2021) · Anaesthesia · doi:10.1111/anae.15480 · Cited by 6
Addressing opioid misuse: Hero Help as a recovery and behavioural health response
Donnelly, E. A., Stenger, M., Streisel, S., O’Connell, D. J., & Arnold, J. (2021) · Journal of Community Safety and Well-Being · doi:10.35502/jcswb.191 · Cited by 6
Identifying the changing age distribution of opioid-related mortality with high-frequency data
Paul, L. A., Li, Y., Leece, P., Gomes, T., Bayoumi, A. M., Herring, J., Murray, R., & Brown, P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265509 · Cited by 7
Adverse Childhood Experiences and Overdose: Lessons From Overdose Data to Action
Wisdom, A. C., Govindu, M., Liu, S. J., Meyers, C. M., Mellerson, J. L., Gervin, D. W., DePadilla, L. M., & Holland, K. M. (2022) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2021.11.015 · Cited by 6
A Patient-Centered Nurse-Supported Primary Care-Based Collaborative Care Program to Treat Opioid Use Disorder and Depression; Design and Protocol for the MI-CARE Randomized Controlled Trial
DeBar, L., Bushey, M. A., Kroenke, K., Bobb, J. F., Schoenbaum, M., Thompson, E., Justice, M., Zatzick, D., Hamilton, L., McMullen, C. K., et al. (2023) · Contemporary Clinical Trials · doi:10.1016/j.cct.2023.107124 · Cited by 6
Novel Opioid Safety Clinic Initiative to Deliver Guideline-Concordant Chronic Opioid Therapy in Primary Care
Binswanger, I. A., Joseph, N., Hanratty, R. L., Gardner, E. M., Durfee, J., Narwaney, K. J., Breslin, K. D., Mueller, S. R., & Glanz, J. M. (2018) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2018.09.005 · Cited by 6
Local Health Department Activities to Reduce Emergency Department Visits for Substance Use Disorders
Novak, P. J., Bloodworth, R. F., Green, K., & Chen, J. (2019) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000161 · Cited by 6
Addressing the Opioid Crisis: Medical Student Instruction in Opioid Drug Pharmacology, Pain Management, and Substance Use Disorders
Cox, B. M., Cote, T. E., & Lucki, I. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.257329 · Cited by 6
Supporting Physicians and Practice Teams in Efforts to Address the Opioid Epidemic
Letourneau, L. M., Ritzo, J., Shonk, R., Eichler, M., & Sy, S. (2019) · The Annals of Family Medicine · doi:10.1370/afm.2408 · Cited by 6
State criminal justice policy context and opioid agonist treatment delivery among opioid treatment admissions, 2015
Mantha, S., Mauro, P. M., Mauro, C., & Martins, S. S. (2019) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2019.107654 · Cited by 6
Ethics Consultations Related to Opioid Use Disorder
Bandini, J. I., Courtwright, A., Rubin, E. B., Erler, K. S., Zwirner, M., Cremens, M. C., McCoy, T. H., & Robinson, E. M. (2019) · Psychosomatics · doi:10.1016/j.psym.2019.10.003 · Cited by 6
Opioid antidote induced pulmonary edema and lung injury
Yarlagadda, K., Kim, J., Kanderi, T., Sendil, S., & Nookala, V. (2020) · Respiratory Medicine Case Reports · doi:10.1016/j.rmcr.2020.101107 · Cited by 6
Biomarkers to predict staging and treatment response in opioid dependence: A narrative review
Vorspan, F., Cynthia Marie-claire, A., Bellivier, F., & Bloch, V. (2021) · Drug Development Research · doi:10.1002/ddr.21789 · Cited by 6
Describing the changing relationship between opioid prescribing rates and overdose mortality: A novel county-level metric
Hall, E. W., Bradley, H. M., Jones, J. S., Rosenberg, E. S., Lopman, B. A., & Sullivan, P. S. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108761 · Cited by 6
Provider education leads to sustained reduction in pediatric opioid prescribing after surgery
Slater, B. J., Corvin, C. G., Heiss, K. F., Vandewalle, R. J., Shah, S. R., Cunningham, M. E., Huang, E. Y., Lipskar, A. M., Denning, N., Dassinger, M. S., et al. (2021) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2021.08.004 · Cited by 6
COVID-19 and opioid use disorder
Mumba, M. N., Jaiswal, J., Smith, N. L., Mugoya, G. C. T., Brown, W. C., & Davis, L. L. (2021) · Nursing · doi:10.1097/01.nurse.0000798204.89531.95 · Cited by 6
Status of US State Laws Mandating Timely Reporting of Nonfatal Overdose
Davis, C. S., Green, T. C., Hernandez-Delgado, H., & Lieberman, A. J. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304589 · Cited by 6
Comparison of Postoperative Opioid Use After Anterior Cervical Diskectomy and Fusion or Posterior Cervical Fusion
Lee, Y. A., Issa, T. Z., Lambrechts, M. J., Brush, P. L., Toci, G. R., Reddy, Y., Fras, S. I., Mangan, J. J., Canseco, J. A., Kurd, M. F., et al. (2023) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-23-00003 · Cited by 5
Optimizing Contingency Management with Reinforcement Learning
Kim, Y.-G., Brandt, L., Cheung, K., Nunes, E. V., Roll, J., Luo, S. X., & Liu, Y. (2025) · IEEE International Conference on Healthcare Informatics (ICHI) · doi:10.1109/ichi64645.2025.00051 · Cited by 5
An evaluation method for developing abuse-deterrent opioid formulations with agonist and antagonist combinations using conditioned place preference
Zhang, X., Kitaichi, K., Mouri, A., Zhou, X., Nabeshima, T., Yamada, K., & Nagai, T. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.11.072 · Cited by 5
Healthcare Provider Reports on Social Determinants of Health in Opioid Treatment
Cambron, C., Gouripeddi, R., & Facelli, J. C. (2023) · Psych · doi:10.3390/psych5010007 · Cited by 5
“No Good Choice”: What are the Issues of Having no Harm Reduction Strategies in Hospitals?
Forchuk, C., Serrato, J., Scott, L., Rudnick, A., Dickey, C. C., & Silverman, M. E. (2023) · Substance Abuse Research and Treatment · doi:10.1177/11782218231186065 · Cited by 5
Mortality among people who inject drugs – the interwoven roles of fentanyl and HIV: a community-based cohort study
Salekešin, M., Vorobjov, S., Jarlais, D. C. D., & Uusküla, A. (2023) · European Journal of Public Health · doi:10.1093/eurpub/ckad204 · Cited by 5
Evaluation of a tiered opioid prescription algorithm in an ERAS pathway: exploring opportunities for further refinement
Basabe, M. S., Suki, T. S., Munsell, M. F., Iniesta, M. D., Lopez, J. E. G., Hillman, R. T., Cain, K. E., Huepenbecker, S. P., Mena, G. E., Taylor, J. S., et al. (2023) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2023-004948 · Cited by 5
Intentional benzodiazepine poisoning in older adults reported to United States Poison Centers
Choi, N. G., Choi, B. Y., Marti, C. N., & Baker, D. (2024) · Clinical Toxicology · doi:10.1080/15563650.2024.2334828 · Cited by 5
Contemporary burden and trends of opioid-overdose mortality in New York State
Karaye, I. M., Gonzalez, J., Owens, S., Jalal, S., Sosa, S., Alexander, K., Thomas, M., Granger, G. G., Markowitz, W., & Kyriacou, C. M. (2024) · Preventive Medicine · doi:10.1016/j.ypmed.2024.108010 · Cited by 5
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type
Hayes, C. J., Raciborski, R. A., Nowak, M., Acharya, M., Nunes, E. V., & Winhusen, T. M. (2024) · Addiction · doi:10.1111/add.16659 · Cited by 5
Examining naloxone access and interest in secondary naloxone distribution on an American Indian Reservation in the Northern Midwest of the United States
Schneider, K. E., Allen, S. T., O’Rourke, A., Reid, M. C., Conrad, M. A., Hughes, P., Palombi, L. C., Wakemup, T., Medley, A., & Walls, M. L. (2024) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2024.100285 · Cited by 5
Effect of cannabis use history on postoperative opioid utilization in lumbar fusion patients: an American retrospective study
Mirpuri, P., Khalid, S. I., King, P., Roy, J. M., Elsamadicy, A. A., Mehta, A. I., & Adogwa, O. (2024) · Asian Spine Journal · doi:10.31616/asj.2024.0194 · Cited by 5
Nasal absorption of oxycodone predicted using a novel computational fluid dynamics-physiologically based pharmacokinetic model
Walenga, R. L., Babiskin, A. H., Boyce, H. J., Feng, X. L., Zidan, A. S., Kamal, N. S., Xu, X., Kim, M., & Zhao, L. Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.12.049 · Cited by 5
Pharmacy harm reduction practices to help reduce opioid overdoses, Arizona 2023
Meyerson, B. E., Richter, S., Gordon, R., Chang, E. P. Y., Vadiei, N., Eldridge, L. A., Higbie, E. O., Pal, A. A., Seckar-Martinez, A., Newgass, K., et al. (2025) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2025.102348 · Cited by 5
Neurobiological Mechanisms of Action of Transcranial Direct Current Stimulation (tDCS) in the Treatment of Substance Use Disorders (SUDs)—A Review
Chmiel, J., & Kurpas, D. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14144899 · Cited by 6
Tapering of prescribed opioids in patients with long-term non-malignant pain (TOPIO)—efficacy and effects on pain, pain cognitions, and quality of life: a study protocol for a randomized controlled clinical trial with a 12-month follow-up
Grelz, H., Midlöv, P., Håkansson, A., Jakobsson, U., Marcelo, R. F., & Ringqvist, Å. (2021) · Trials · doi:10.1186/s13063-021-05449-5 · Cited by 5
Optimization of Prescription Drug Monitoring Program to Overcome Opioid Epidemic in West Virginia
Al-Astal, A.-E. Y., Sodhi, K., & Lakhani, H. V. (2022) · Cureus · doi:10.7759/cureus.22434 · Cited by 5
Patient Factors Associated with High Opioid Consumption after Common Surgical Procedures Following State-Mandated Opioid Prescription Regulations
Sacklow, A., Malhotra, A. K., Jones, E., CALLAS, P. W., Fujii, M. H., & Colovos, C. (2022) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000185 · Cited by 5
Must‐access prescription drug monitoring programs and retail opioid sales
Shakya, S., & Hodges, C. D. (2022) · Contemporary Economic Policy · doi:10.1111/coep.12586 · Cited by 5
Enhancing and Leveraging the West Virginia's Prescription Drug Monitoring Program (PDMP) for Public Health Surveillance and Clinical Decision Making: A Case Study
Wood, N., Mells, J., Dotson, T., & Jeffries, J. E. (2022) · Journal of Public Health Management and Practice · doi:10.1097/phh.0000000000001660 · Cited by 5
A phase 1 randomized, placebo-controlled study to investigate potential interactions between ASP8062, a positive allosteric modulator of the GABA B receptor, and morphine in recreational opioid users
Ito, M., Walzer, M., Blauwet, M. B., Spence, A., Heo, N., Kelsh, D., Blahunka, P. C., Erdman, J., Alsharif, M. N., & Marek, G. J. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231167852 · Cited by 5
A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States
Chiosi, J. J., Mueller, P. P., Chhatwal, J., & Ciaranello, A. L. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09773-1 · Cited by 6
Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances
Castillo, F., Hu, M., Liu, Y., Balise, R. R., Weiss, R. D., Rotrosen, J., Nunes, E. V., Saxon, A. J., Feaster, D. J., & Luo, S. X. (2023) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2023.110926 · Cited by 5
Reducing opioid prescribing after ambulatory breast reconstruction surgery
Fearon, N. J., Kurtzman, J. S., Benfante, N. E., Assel, M. J., Vickers, A. J., Carlsson, S., Laudone, V. P., Levine, M. R., Simon, B. A., Mehrara, B. J., et al. (2023) · Journal of Surgical Oncology · doi:10.1002/jso.27427 · Cited by 5
Drug-related physician continuing medical education requirements, 2010–2020
Davis, C. S., Carr, D. H., & Stein, B. D. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209356 · Cited by 5
Gabapentinoids Increase the Potency of Fentanyl and Heroin and Decrease the Potency of Naloxone to Antagonize Fentanyl and Heroin in Rats Discriminating Fentanyl
Hiranita, T., Flynn, S. M., Grisham, A. K., Mijares, A. E., Murphy, E. N., & France, C. P. (2024) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.124.002323 · Cited by 5
Interactions of pain and opioids on conditioned place preference in rodents
Barattini, A. E., & Pahng, A. R. (2024) · Psychopharmacology · doi:10.1007/s00213-024-06719-1 · Cited by 5
Emerging Legal Threats to the Public's Health
Hodge, J. G., Wetter, S., Barraza, L. F., Morcelle, M., Chronister, D., Hess, A., Piatt, J. L., & Johnson, W. (2018) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110518782969 · Cited by 5
TOXICOLOGICAL CHARACTERISTIC OF DESIGNER DRUGS FROM THE GROUP OF SYNTHETIC OPIOIDS
Головко, А. И., Ivanov, M. B., Rejniuk, V. L., Ivnitsky, Y. Y., Barinov, V. A., & Borodavko, V. K. (2019) · Toxicological Review · doi:10.36946/0869-7922-2019-1-3-11 · Cited by 5
Opioid-prescribing Habits of Practitioner and Educator Members of the American Association of Endodontists: Report of a National Survey
Alghofaily, M. M., Romberg, E., Aldahmash, S. A., & Tordik, P. A. (2019) · Journal of Endodontics · doi:10.1016/j.joen.2019.06.007 · Cited by 5
Evaluation of low-intensity initiatives to improve linkage to care for emergency department patients with opioid use disorder
Shaw, I., Faryar, K. A., Ryan, R. J., Ancona, R. M., Fernández, F. J. F., & Lyons, M. S. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.09.007 · Cited by 5
A cross-sectional study of opioid involvement in non-poisoning suicide – risks and prevention opportunities
Mason, M., Welch, S. B., McLone, S. G., Bartell, T. R., Lank, P. M., Sheehan, K., & Post, L. A. (2021) · BMC Public Health · doi:10.1186/s12889-021-10792-y · Cited by 5
Perceived risk of opioid use disorder secondary to opioid analgesic medication use by the general population in France
Lavergne, J., Debin, M., Blanchon, T., Colizza, V., Dassieu, L., Gimenez, L., Kuetche, C. K., Lapeyre‐Mestre, M., & Dupouy, J. (2021) · European Journal of Pain · doi:10.1002/ejp.1901 · Cited by 5
Translation of Legislation: Effect Analysis of Michigan Opioid Law on Clinical Practice
McMichael, B., Michaels, R. E., Lowy, J., Reddy, S., Keilin, C. A., Lin, J., Lynch, W. R., Wakeam, E., Reddy, R. M., Chang, A. C., et al. (2022) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2022.03.057 · Cited by 5
Longitudinal trajectories of prescription opioid misuse in adolescents
Kelley‐Quon, L. I., Cho, J., Barrington‐Trimis, J. L., Kipke, M. D., Clapp, J. D., Krueger, E. A., & Leventhal, A. M. (2022) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2022.109470 · Cited by 5
Integration of Life Care Specialists Into Orthopaedic Trauma Care to Improve Postoperative Outcomes: A Pilot Study
Giordano, N. A., Aspang, J. S. U., Baker, J., Medline, A., Rice, C. W., Barrell, B., Kirk, L., Ortega, E., Wallace, M., Steck, A., et al. (2022) · Pain Management Nursing · doi:10.1016/j.pmn.2022.03.010 · Cited by 5
County-Level Economic Changes and Drug Mortality in the United States: Evidence from the Great Recession
Kim, Y., Cano, M. N., Oh, S., & Betz, M. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192316261 · Cited by 5
Clinician Perceptions of Receiving Different Forms of Feedback on their Opioid Prescribing
Klaiman, T. A., Nelson, M. N., Yan, X. S., Navathe, A. S., Patel, M. S., Refai, F., Delgado, M. K., Pagnotti, D. R., & Liao, J. M. (2022) · American Journal of Medical Quality · doi:10.1097/jmq.0000000000000092 · Cited by 5
The Relative Risk of Toxico-Clinical Parameters with respect to Poisoning Severity and Outcomes in Patients with Acute Poisoning
Eizadi‐Mood, N., Heshmat, R., Meamar, R., & Motamedi, N. (2022) · Advanced Biomedical Research · doi:10.4103/abr.abr_290_21 · Cited by 5

Authors: Hedegaard, H., Miniño, A., Spencer, M. R., & Warner, M.
ORCID: Hedegaard, Holly
Publisher: National Center for Health Statistics ( U.S.)
Published: 2021-12-30
DOI: 10.15620/cdc:112340
OpenAlex: W4200337926
Cited by: 1,283
References: 4
Citations by year: 2026: 25 · 2025: 93 · 2024: 130 · 2023: 186 · 2022: 147 · 2021: 168
Type: report
Language: en
Open access: gold
doi.org
Licence: public-domain
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
Keywords: drug overdose deaths, opioid overdose, stimulant overdose, mortality trends, drug-related deaths, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug Overdose Deaths in the United States, 1999–2020

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks